# Pneumocystis Pneumonia in a Patient with Systemic Lupus Erythematosus: Cytology Confirmed by Electron Microscopy and Microdiatat Evaluation
Quaglee Dragontacos


## Abstract
Cryptococcus gattii is a globally distributed fungus responsible for several serious human diseases. C. gattii typically infects immunocompromised patients, especially neutropenia, and causes meningitis in healthy individuals. C. gattii has several virulence factors, including a G protein-coupled receptor (GCRR) and a CCR-210 component, which together may mediate its multiple virulence traits. In this study, we analyzed the role of a GCRR ligand in cryptococcosis pathogenesis. Our results demonstrate that GCRR deficiency increases the frequency of cryptococcosis but decreases the number of isolated cryptococcal strains. This is the first time an additional virulence factor of cryptococcal origin has been reported to be restricted to this group of patients.

Cryptococcus gattii causes ~400,000 deaths annually in human and animals, with over one million cases of cryptococcosis worldwide annually. Cryptococcus gattii is an emerging life-threatening human fungal pathogen that causes ~200,000 deaths per year. Despite that, the majority of treatment-resistant cryptococcosis cases are found in Africa, and despite advances in antifungal drug therapy, life-threatening infections continue to occur. The underlying mechanism of the different virulence traits of C. gattii is still poorly understood. The present study deals with the differential frequencies of the GCRR and other virulence factors in C. gattii, identifying a role for a GCRR-dependent mechanism that may explain the different virulence traits of this important fungal pathogen.

Cryptococcus gattii causes hundreds of thousands of deaths each year, mainly in Africa. This study reports on the differential frequencies of the different virulence traits of C. gattii, finding that different groups of patients are subjected to different treatments. The results suggest that these differences may reflect the differential distribution of the different virulence factors among different groups of patients, with the differences mainly related to the different treatment-limiting factors of C. gattii.


## Introduction

Patient’s physical examination revealed a deep cyst and perforated lesion in the left lower lobe and the lesion was not detected by electron microscop. However, the patient's EEM revealed the disease to be diffusely formed in the cyst. The patient was treated with a systemic anti-rheumatic drug solution and had a good result after 6 weeks. However, the patient's EEM did not include the disease, and the lesion was not detected by electron microscopy. A subsequent EEM, obtained by a second microbiologist, confirmed the disease.

The Infectious Disease Society of America (IDSA) and European Society for Proposite Medicines (ESP) guidelines recommend the use of amphotericin B (AMB) to treat patients with rheumatoid arthritis (RA), which is a common RA, plus limited empirical empirical treatment. The guideline also recommends amphotericin B as prophylaxis against treatment-resistant rheumatoid arthritis (TRRA).

According to the IDSA guidelines, AMB is an empiric drug with activity against fungal infections in the past. However, the rate of adverse events and severe side effects of amphotericin B has been reported in patients with rheumatoid arthritis who receive amphotericin B treatment [2].

The European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) recommendations against amphotericin B is to use AMB alone as prophylaxis against rheumatoid arthritis and to not treat patients with rheumatoid arthritis with AMB.

The IDSA guideline against AMB prophylaxis recommends only a minimum of four monthly courses with oral amphotericin B (IVB) plus fluconazole (FLC) to treat patients with rheumatoid arthritis. However, these courses should be initiated as recommendations in the initial EORTC/MSG EORTC/MSG guideline, which may be extended.

The European Organization for Research and Treatment of Cancer/Human Tumor (EORTC/MSG) consensus position on amphotericin B is to first determine the therapy for RA with IVB and then follow up with IVB/MSG recommendations.


## Methods

Laboratory methods
Laboratory methods included routine blood cultures, ELISA and India ink staining, histological specimens and histopathological examination for all patients with CNS infectio.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.

Laboratory methods included ELISA and histopathological examination for all patients with CNS infection.


## Results
neoformans infection in a patient with systemic Lupus Erythematosus infectio. The patient presented with an apparent chest pain and was admitted with fever, headache, and abdominal pain. After intubation, he was admitted to a local hospital with a lung abscess, and the patient had chest pain, headache, and abdominal pain. On admission, he was admitted to the hospital with a fever, headache, and abdominal pain. The patient had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain. He was admitted to the hospital with a chest pain, chest pain, and abdominal pain. A neutropenia was diagnosed and the patient was admitted with fever, headache, and abdominal pain. The patient had an intestinal tract abscess and was admitted with fever, headache, and abdominal pain. He was admitted to the hospital with a chest pain, chest pain, and abdominal pain.

Etiology
The patient was admitted to the hospital with a chest pain, headache, and abdominal pain. He had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain. The patient was admitted to the hospital with a chest pain, chest pain, and abdominal pain. The patient had lung abscess, and was admitted with fever, headache, and abdominal pain. The patient was admitted with a chest pain, chest pain, and abdominal pain. The patient was admitted with a heart condition. The patient had a mild fever and was admitted with fever, headache, and abdominal pain. The patient had pulmonary disease and was admitted with fever, headache, and abdominal pain.

Epidemiology
The patient had a progressive fever, and was admitted with fever, headache, and abdominal pain. He had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain. The patient was admitted with a fever, headache, and abdominal pain. The patient had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain. The patient had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain. The patient had an esophagus with the lesion being divided into two parts. The patient had a progressive fever and was admitted with fever, headache, and abdominal pain. The patient had disseminated pulmonary disease and was admitted with fever, headache, and abdominal pain.


## Discussion
It is a secondary endobronchial infection, which can be caused by inhalation of spores, by a single inoculation of spores from the patient’s body, or by the introduction of spores from another patient’s body into the patient’s bloodstrea. Cytomegaly can occur in any of the following conditions:

Sulphuriasis (Sulphuriasis), malaria, cerebral malaria, or cerebral sepsis

Chronic pulmonary mycosis

S. pombe (pneumonia), pulmonary mycosis, and pulmonary sarcoma

Pulmonary sarcoma is a rare disease, and it can be caused by a single inoculation of spores from the patient’s body or by the introduction of spores from another patient’s body into the patient’s bloodstream.

Pulmonary sarcoma is a condition that occurs in healthy individuals, and it usually occurs in childhood, but can also occur in patients with a predisposing condition, such as diabetes mellitus, malignancy, or sarcoidosis. Pulmonary sarcoma is caused by pulmonary fibrosis caused by direct deposition of fibrous tissue or by the formation of dense granulomas, which are not easily diagnosed and treated by bronchoscopy. Fibrosis is often associated with pulmonary tuberculosis and bacteremia.

Fibrosis is the most common form of fibrosis in patients with severe disease, and the most severe forms of fibrosis occur in patients with normal lung function. Patients with fibrosis have a poor prognosis, and early diagnosis is critical to avoid morbidity and mortality. Bronchoscopy is the first line of defense in the diagnosis of fibrosis, and it is often the first diagnostic method available in the diagnosis of fibrosis. Bronchoscopy is a more invasive procedure, and it is often used to assess the extent of fibrosis, which can range from simple fibrosis to extensive fibrosis. In patients with fibrosis, a simple bronchoscopy should be performed to identify fibrosis. If the bronchoscopy is performed, the bronchoscope should be placed at the base of the bronchus to provide a direct visualization of the fibrosis.

Bronchoscopy can be performed to confirm the diagnosis of fibrosis.
